These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18007958)

  • 21. A recombinantly tailored β-defensin that displays intensive macropinocytosis-mediated uptake exerting potent efficacy against K-Ras mutant pancreatic cancer.
    Du Y; Shang BY; Sheng WJ; Zhang SH; Li Y; Miao QF; Zhen YS
    Oncotarget; 2016 Sep; 7(36):58418-58434. PubMed ID: 27517152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation.
    Aoki K; Yoshida T; Matsumoto N; Ide H; Sugimura T; Terada M
    Mol Carcinog; 1997 Oct; 20(2):251-8. PubMed ID: 9364215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmid expression of a peptide that selectively blocks oncogenic ras-p21-induced oocyte maturation.
    Kovac C; Clie L; Morin J; Friedman FK; Robinson R; Chung DL; Kanovsky M; Flom J; Brandt-Rauf PW; Yamaizumi Z; Michl J; Pincus MR
    Cancer Chemother Pharmacol; 2001 Jul; 48(1):9-14. PubMed ID: 11488531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln-->Leu61).
    Gedde-Dahl T; Spurkland A; Eriksen JA; Thorsby E; Gaudernack G
    Int Immunol; 1992 Nov; 4(11):1331-7. PubMed ID: 1282032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
    Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of phosphoinositide 3-kinase in the aggressive tumor growth of HT1080 human fibrosarcoma cells.
    Gupta S; Stuffrein S; Plattner R; Tencati M; Gray C; Whang YE; Stanbridge EJ
    Mol Cell Biol; 2001 Sep; 21(17):5846-56. PubMed ID: 11486024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loop domain peptides from the SOS ras-guanine nucleotide exchange protein, identified from molecular dynamics calculations, strongly inhibit ras signaling.
    Chie L; Friedman FK; Duncan T; Chen JM; Chung D; Pincus M
    Protein J; 2004 Apr; 23(3):229-34. PubMed ID: 15200054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells.
    Halaschek-Wiener J; Wacheck V; Schlagbauer-Wadl H; Wolff K; Kloog Y; Jansen B
    Mol Med; 2000 Aug; 6(8):693-704. PubMed ID: 11055588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the computed three-dimensional structures of oncogenic forms (bound to GDP) of the ras-gene-encoded p21 protein with the structure of the normal (non-transforming) wild-type protein.
    Monaco R; Chen JM; Chung D; Brandt-Rauf P; Pincus MR
    J Protein Chem; 1995 Aug; 14(6):457-66. PubMed ID: 8593186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide.
    Sookraj KA; Bowne WB; Adler V; Sarafraz-Yazdi E; Michl J; Pincus MR
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):325-31. PubMed ID: 20182728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides.
    Gedde-Dahl T; Eriksen JA; Thorsby E; Gaudernack G
    Hum Immunol; 1992 Apr; 33(4):266-74. PubMed ID: 1639630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular expression of an antibody fragment-neutralizing p21 ras promotes tumor regression.
    Cochet O; Kenigsberg M; Delumeau I; Virone-Oddos A; Multon MC; Fridman WH; Schweighoffer F; Teillaud JL; Tocqué B
    Cancer Res; 1998 Mar; 58(6):1170-6. PubMed ID: 9515802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro.
    Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
    Int J Oncol; 2016 May; 48(5):1955-64. PubMed ID: 26935290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of the three-dimensional structure of the rap-1A protein from its homology to the ras-gene-encoded p21 protein.
    Chen JM; Grad R; Monaco R; Pincus MR
    J Protein Chem; 1996 Jan; 15(1):11-5. PubMed ID: 8838585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poptosis or Peptide-Induced Transmembrane Pore Formation: A Novel Way to Kill Cancer Cells without Affecting Normal Cells.
    Pincus MR; Silberstein M; Zohar N; Sarafraz-Yazdi E; Bowne WB
    Biomedicines; 2024 May; 12(6):. PubMed ID: 38927351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction and progression of the transformed phenotype in cloned rat embryo fibroblast cells: studies employing type 5 adenovirus and wild-type and mutant Ha-ras oncogenes.
    Boylan JF; Shih TY; Fisher PB; Zimmer SG
    Mol Carcinog; 1992; 5(2):118-28. PubMed ID: 1554410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the low energy conformations of an oncogenic and a non-oncogenic p21 protein, neither of which binds GTP or GDP.
    Liwo A; Gibson KD; Scheraga HA; Brandt-Rauf PW; Monaco R; Pincus MR
    J Protein Chem; 1994 Feb; 13(2):237-51. PubMed ID: 8060496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A peptide from the GAP-binding domain of the ras-p21 protein and azatyrosine block ras-induced maturation of Xenopus oocytes.
    Chung DL; Brandt-Rauf P; Murphy RB; Nishimura S; Yamaizumi Z; Weinstein IB; Pincus MR
    Anticancer Res; 1991; 11(4):1373-8. PubMed ID: 1746893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
    Kuo ML; Chou YW; Chau YP; Huang TS
    Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.